Skip to main content
. 2021 Jan 22;100(3):e23830. doi: 10.1097/MD.0000000000023830

Figure 1.

Figure 1

Flow chart of study design. A total of 516 patients with proven multiple-vessel coronary artery disease who received R-CABG, and C-CABG were included in the final analysis.